R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 49.6 CNY -4.39% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
R&G PharmaStudies Co Ltd?
Write Note

R&G PharmaStudies Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

R&G PharmaStudies Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
R
R&G PharmaStudies Co Ltd
SZSE:301333
Effect of Foreign Exchange Rates
ÂĄ1.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Effect of Foreign Exchange Rates
-ÂĄ108.9m
CAGR 3-Years
-6%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Effect of Foreign Exchange Rates
ÂĄ56.6m
CAGR 3-Years
N/A
CAGR 5-Years
82%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Effect of Foreign Exchange Rates
-ÂĄ73.3m
CAGR 3-Years
47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Effect of Foreign Exchange Rates
-ÂĄ35.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-41%
W
WuXi XDC Cayman Inc
HKEX:2268
Effect of Foreign Exchange Rates
-ÂĄ51.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

R&G PharmaStudies Co Ltd
Glance View

Market Cap
4.8B CNY
Industry
Life Sciences Tools & Services

R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. The company is headquartered in Beijing, Beijing and currently employs 1,926 full-time employees. The company went IPO on 2022-08-02. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.

Intrinsic Value
59.36 CNY
Undervaluation 16%
Intrinsic Value
Price
R

See Also

What is R&G PharmaStudies Co Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
1.1m CNY

Based on the financial report for Dec 31, 2023, R&G PharmaStudies Co Ltd's Effect of Foreign Exchange Rates amounts to 1.1m CNY.

What is R&G PharmaStudies Co Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 1Y
-80%

Over the last year, the Effect of Foreign Exchange Rates growth was -80%.

Back to Top